ClinicalTrials.govpublic full text
A Study Using Swedish Registries to Find Out How Many People With Type 2 Diabetes Had Cardiovascular Disease and Started Treatment With Empagliflozin Between 2015 and 2017
type 2 diabetes mellitus
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 325213
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.